INFANRIX (GlaxoSmithKline Biologicals SA)


Welcome to the PulseAid listing for the INFANRIX drug offered from GlaxoSmithKline Biologicals SA. This Inactivated Clostridium Tetani Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Tetanus Toxoid [Chemical/Ingredient],Inactivated Corynebacterium Diphtheriae Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Diphtheria Toxoid [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Pertussis Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline Biologicals SA
NON-PROPRIETARY NAME: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
SUBSTANCE NAME: CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE I
TYPE: VACCINE
PHARMA CLASS: Inactivated Clostridium Tetani Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Tetanus Toxoid [Chemical/Ingredient],Inactivated Corynebacterium Diphtheriae Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Diphtheria Toxoid [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Pertussis Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient],Inactivated Bordetella Pertussis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Pertussis Vaccine [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-07-24
END MARKETING DATE: 0000-00-00


INFANRIX VACCINE Details:

Item DescriptionINFANRIX from GlaxoSmithKline Biologicals SA
LABELER NAME: GlaxoSmithKline Biologicals SA
DEA SCHEDULE:
ACTIVE STRENGTH: 10; 25; 25; 25; 8([iU]/.5mL; [iU]/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2009-07-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58160-810_4518e30b-22cd-4d34-9e12-04758635a10b
PRODUCT NDC: 58160-810
APPLICATION NUMBER: BLA103647

Other CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE I Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline Biologicals SAINFANRIX